4
Changes in Ownership
Neurogene Inc. Filed Acc 0001209191-18-046095
Options or other derivatives
- Chief Operating Officer acquired 145,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MacKenzie Lloyd · Chief Operating Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-08-07 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +145,000 | 145,000 | D |
Loading xslF345X03/doc4.xml…